MARKET

BLRX

BLRX

Biolinerx
NASDAQ
0.6945
-0.0104
-1.48%
After Hours: 0.7725 +0.078 +11.23% 19:28 12/01 EST
OPEN
0.7050
PREV CLOSE
0.7049
HIGH
0.7500
LOW
0.6880
VOLUME
224.70K
TURNOVER
0
52 WEEK HIGH
3.020
52 WEEK LOW
0.5700
MARKET CAP
42.73M
P/E (TTM)
-1.4840
1D
5D
1M
3M
1Y
5Y
BioLineRx to Participate in the 12th Annual LifeSci Partners Corporate Access Event
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a pre-commercial-stage biopharmaceutical company focused on oncology, today announced that management will participate in the 12th Annual LifeSci Partners Corporate Access Event, taking place January 9-11, 2023, ...
PR Newswire · 3d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 11/21 21:32
biolinerx GAAP EPS of -$0.01
Seekingalpha · 11/15 12:05
BRIEF-Biolinerx Reports Third Quarter 2022 Financial Results
Reuters · 11/15 12:04
BioLine Rx Q3 EPS $(0.01) Beats $(0.11) Estimate. Cash, Cash Equivalents, And Short-Term Bank Deposits of $57.3M
Benzinga · 11/15 12:03
BioLineRx Reports Third Quarter 2022 Financial Results and Recent Corporate and Portfolio Updates
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a pre-commercial-stage biopharmaceutical company focused on oncology, today reported third quarter financial results and recent corporate and portfolio updates.
PR Newswire · 11/15 12:00
Notable earnings before Tuesday's open
Seekingalpha · 11/14 15:47
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
Benzinga · 11/11 10:10
More
About BLRX
BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.

Webull offers kinds of BioLine RX Ltd - ADR stock information, including NASDAQ:BLRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BLRX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BLRX stock methods without spending real money on the virtual paper trading platform.